| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 2,434,100 | 1,486,900 | 1,126,300 | 1,295,900 | | Cost of Revenue | 1,954,900 | 1,244,600 | 955,600 | 1,154,300 | | | Gross Profit | 479,200 | 242,300 | 170,700 | 141,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 114,800 | 106,700 | 107,900 | 103,200 | | Non Recurring | 23,300 | 2,000 |
-
| 1,197,800 | | Others | 15,400 | 15,500 | 14,800 | 15,800 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 325,700 | 118,100 | 48,000 | (1,175,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,100 | 6,500 | 4,100 | (1,900) | | Earnings Before Interest And Taxes | 326,800 | 124,600 | 52,100 | (1,177,100) | | Interest Expense | 50,800 | 63,400 | 62,700 | 41,900 | | Income Before Tax | 276,000 | 61,200 | (10,600) | (1,219,000) | | Income Tax Expense | 103,200 | 8,000 | 900 | (26,800) | | Minority Interest |
-
| 200 | 300 | 200 | | | | Net Income From Continuing Ops | 172,500 | 52,400 | (12,100) | (1,192,000) | | | Non-recurring Events | | Discontinued Operations | (2,900) | 87,900 | (14,400) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 169,600 | 140,300 | (26,500) | (1,192,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $169,600 | $140,300 | ($26,500) | ($1,192,000) |
|
0.34% Nasdaq 
0.12 (0.31%) 
Income Statement
